Framework for management and controversial aspects of principal supraventricular tachycardia types pharmacotherapy

Cover Page

Cite item

Full Text

Abstract

Supraventricular tachycardia (SVT) is a unifying term that embodies various types of tachycardia with narrow QRS complexes (less than 0.12 s). These types are widely represented in general population (2.2 per 1000 population) and can be whether paroxysmal or chronic. It was established that SVT can manifest both in children and in adults. The article presents a modern view on strategy and tactics of rescue and preventive therapy in patients with SVT. The information is presented according to international recommendations on patients with SVT management, results of several controlled trials and personal authors experience in arrhythmia management. Some controversial aspects of SVT management are also discussed.

About the authors

Yu. A Bunin

Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation

д-р мед. наук, проф. каф. кардиологии 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1

S. V Miklishanskaya

Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation

Email: kvant83@list.ru
канд. мед. наук, ассистент каф. кардиологии 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1

References

  1. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. Eur Heart J 2003; 24: 1857-97.
  2. ACC/AHA/HRS guidelines for the management adult patients with supraventricular tachycardia. Circulation 2015; http://circ.ahajournals.org/lookup/suppl/doi:10.1161
  3. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Europace 2017; 19: 465-511.
  4. Orejarena L.A, Vidaillet H, De Stefano F. et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998; 31: 150-7.
  5. Goyal R, Zivin A, Souza J et al. Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J 1996; 132: 765-7.
  6. Lee S.H, Chen S.A, Wu T.J et al. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol 1995; 76: 675-8.
  7. Cain N, Irving C, Webber S et al. Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood. Am J Cardiol 2013; 112: 961-5.
  8. Abe H, Nagatomo T, Kobayashi H et al. Neurohumoral and hemodynamic mechanisms of diuresis during atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol 1997; 20: 2783-8.
  9. Olgin J.E, Zipes D.P. Specific arrhythmias: diagnosis and treatment. In Braunwald E, Zipes D, Libby P, Bonow R. (eds). Heart disease. Saunders Company 2005; 803-63.
  10. Luber S, Brady W.J, Joyce T et al. Paroxysmal supraventricular tachycardia: outcome after EDcare. Am J Emerg Med 2001; 19: 40-2.
  11. Lim S.H, Anantharaman V, Teo W.S et al. Slow infusion of calcium channel blokers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resuscitation 2009; 80: 523-8.
  12. Bigger J.T, Goldreyer B.N. The mechanism of paroxysmal supraventricular tachycardia in man. Circulation 1970; 42: 673-88.
  13. Dougherty A.H, Jackman W.M, Naccarelli G.V et al. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. Am J Cardiol 1992; 70: 587-92.
  14. Alboni P, Tomasi C, Menozzi C et al. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrecuent, well-tolerated paroxysmal supraventricular tachycardia. J Am Coll Cardiol 2001; 37: 548-53.
  15. Winniford M.D, Fulton K.L, Hillis L.D. Long-term therapy of paroxysmal supraventricular tachycardia: a randomizet, double-blind of digoxin, propranolol and verapamil. Am J Cardiol 1984; 54: 1138-9.
  16. Ferguson J.D, Di Marco J.P. Contemporary management of paroxysmal supraventricular tachycardia. Circulation 2003; 107: 1096-9.
  17. Dorian P, Naccarelli G.V, Coumel P et al. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. Am J Cardiol 1996; 77: 89A-95A.
  18. Бунин Ю.А., Денисов О.Н., Федякина Л.Ф. Профилактическая антиаритмическая фармакотерапия частых пароксизмов фибрилляции предсердий и некоторых видов наджелудочковых тахикардий пропафеноном в сравнении с плацебо. Рос. кардиол. журн. 2010; 5: 77-82.
  19. Малахов В.И., Шугушев Х.Х. Механизмы действия и эффективность этацизина у больных с пароксизмальной атриовентрикулярной узловой реципрокной тахикардией. Кардиология. 1986; 4: 48-54.
  20. Pappone C, Vicedomini G, Manguso F et al. Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry of 2169 patients. Circulation 2014; 130: 811-9.
  21. American heart association guidelines for cardiopulmonary resustitation and emergency cardiovascular care. Circulation 2010; 122: S729-S767.
  22. Spector P, Reynolds M.R, Calkins H et al. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol 2009; 104: 671-77.
  23. Manolis A.S, Katsaros C, Cokkinos D.V. Electrophysiological and electropharmacological studies in pre-excitation syndromes. Eur Heart J 1992; 13: 1489-95.
  24. Chimienti M, Cullen M.T, Casadei G. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Eur Heart J 1995; 16: 1943-51.
  25. Бунин Ю.А. Диагностика и лечение тахиаритмий сердца. Гл. 6. М.: Медпрактика-М, 2011; с. 219-68.

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies